A medication used to treat mild to moderate ulcerative colitis by gradually releasing an anti-inflammatory agent in the intestines, helping to maintain remission.

Indications:
- Treatment of mild to moderate attacks of ulcerative colitis.
- Treatment of active Crohn’s disease.
- Maintenance of remission in patients with ulcerative colitis.
- Reduction of inflammation in the intestines and relief of related symptoms such as abdominal pain, diarrhea, and rectal bleeding.

Main Active Ingredient:
- Mesalazine 500mg extended release per tablet.

Precautions:
- Do not use if allergic to mesalazine or other salicylates.
- Consult your doctor if you have severe liver or kidney disorders, asthma, or blood clotting issues.
- Take care to maintain hydration to prevent kidney stones.
- Monitor for serious skin reactions, blood disorders, myocarditis, or pericarditis.
- Inform your doctor about any other medications you are taking.
- Pregnancy and breastfeeding: consult your doctor before use.
- Seek immediate medical attention in case of overdose or severe side effects.

Side Effects:
- Abdominal Pain.
- Headache.
- Rash.
- Myocarditis.
- Pericarditis.
- Pancreatitis.
- Dizziness.
- Photosensitivity.
- Anemia.
- Liver Disorders.
- Kidney Disorders.
- Peripheral Neuropathy.
- Severe Skin Reactions.
- Hair Loss.
- Muscle Pain.
- Joint Pain.
- Allergic Reactions.

Drug-Drug Interactions:
- May interact with certain medications; inform your doctor of all concurrent treatments.